Genprex, Inc. (GNPX) Covered Calls
There are no covered calls available for Genprex, Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Genprex, Inc. operates as a clinical-stage gene therapy company that develops therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes. It develops drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company's lead product candidate REQORSA (quaratusugene ozeplasmid) for treatment for non-small cell lung cancer (NSCLC) has a multimodal mechanism of action to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis and programmed cell death in cancer cells; modulate immune response against cancer cells; and block mechanisms that create drug resistance. Genprex, Inc. was founded in 2009 and is headquartered in Austin, Texas.
Top 10 Open Interest For May 17 Expiration | Top 5 High Yield | |||||
---|---|---|---|---|---|---|
1. | IWM covered calls | 6. | EEM covered calls | 1. | WOLF covered calls | |
2. | QQQ covered calls | 7. | KWEB covered calls | 2. | FSLY covered calls | |
3. | HYG covered calls | 8. | SLV covered calls | 3. | ENVX covered calls | |
4. | SPY covered calls | 9. | TSLA covered calls | 4. | COIN covered calls | |
5. | FXI covered calls | 10. | EWZ covered calls | 5. | SBUX covered calls |
Want more examples? GNOM Covered Calls | GNR Covered Calls